000283059 001__ 283059
000283059 005__ 20251229124546.0
000283059 0247_ $$2doi$$a10.1002/trc2.70190
000283059 0247_ $$2pmid$$apmid:41445671
000283059 0247_ $$2pmc$$apmc:PMC12722600
000283059 037__ $$aDZNE-2025-01466
000283059 041__ $$aEnglish
000283059 082__ $$a610
000283059 1001_ $$00000-0002-9169-7530$$aBollack, Ariane$$b0
000283059 245__ $$aImplementing robust amyloid PET quantification in multi-center studies: AMYPAD approach to address data acquisition, processing, interpretation and data sharing challenges.
000283059 260__ $$aHoboken, NJ$$bWiley$$c2025
000283059 3367_ $$2DRIVER$$aarticle
000283059 3367_ $$2DataCite$$aOutput Types/Journal article
000283059 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1767008622_31206
000283059 3367_ $$2BibTeX$$aARTICLE
000283059 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000283059 3367_ $$00$$2EndNote$$aJournal Article
000283059 520__ $$aAmyloid-positron emission tomography (PET) is pivotal to Alzheimer's management, with the Centiloid standardizing measurements across tracers. AMYPAD trials (Diagnostic and Patient Management Study [DPMS] and Prognostic and Natural History Study [PNHS]) aimed to validate robust quantification in clinical settings. We report our comprehensive approach to amyloid-PET implementation, comprising scan acquisition, harmonization, data storing, and data sharing strategies.Data from 28 scanners were harmonized using Hoffman phantoms. Three quantification workflows were compared: AmyPype (PET-only), IXICO-LEAP, and the standard Centiloid pipeline (magnetic resonance imaging [MRI]-based). Distributions of Centiloids were assessed using Gaussian Mixture Modeling.Binary quantification showed excellent concordance between pipelines (≥ 96%) and compared to visual reads (>90%). DPMS Centiloids had a bimodal distribution while the PNHS showed a more skewed distribution toward higher Centiloids modeled with three Gaussians (1st Gaussian mean + 2SD = 12 CL, emerging pathology).The harmonization framework, providing strong cross-method correlations in AMYPAD, has been adopted by EARL as the Brain PET/CT accreditation standard and provides a practical approach for other multi-center cohorts to implement similar strategies.We share AMYPAD's end-to-end approach to amyloid positron emission tomography (PET) quantification from data acquisition and handling, harmonization based on Hoffman phantoms, quality control, image processing, to data storage, and data sharing strategies.Centiloid quantification was compared across one PET-only (AmyPype) and two PET-MR pipelines (standard Centiloid and IXIXO-LEAP). Excellent agreement in dichotomized Centiloid valued was observed both between pipelines and when compared to visual reads.Distribution of Centiloid values in the Prognostic and Natural History Study (PNHS) and Diagnostic and Patient Management Study (DPMS) are in line with the initial recruitment strategies of the trials.Harmonization of Amyloid-PET scans framework was adopted by EARL as the Brain PET/CT accreditation standard for multicentre brain PET scans.
000283059 536__ $$0G:(DE-HGF)POF4-353$$a353 - Clinical and Health Care Research (POF4-353)$$cPOF4-353$$fPOF IV$$x0
000283059 588__ $$aDataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
000283059 650_7 $$2Other$$aAlzheimer's
000283059 650_7 $$2Other$$aCentiloid
000283059 650_7 $$2Other$$aPET
000283059 650_7 $$2Other$$aamyloid
000283059 650_7 $$2Other$$aquantification
000283059 7001_ $$00000-0003-1336-6768$$aShekari, Mahnaz$$b1
000283059 7001_ $$00000-0001-6263-1762$$aCollij, Lyduine E$$b2
000283059 7001_ $$00000-0003-1777-4742$$aLuckett, Emma$$b3
000283059 7001_ $$00000-0003-3308-3167$$aGarcía, David Valléz$$b4
000283059 7001_ $$00000-0002-3114-0773$$aMarkiewicz, Pawel$$b5
000283059 7001_ $$aWolz, Robin$$b6
000283059 7001_ $$00000-0002-8197-0118$$aYaqub, Maqsood$$b7
000283059 7001_ $$aWink, Alle Meije$$b8
000283059 7001_ $$aGismondi, Rossella$$b9
000283059 7001_ $$aStephens, Andrew$$b10
000283059 7001_ $$00000-0001-8008-9727$$aVisser, Pieter Jelle$$b11
000283059 7001_ $$aMett, Anja$$b12
000283059 7001_ $$0P:(DE-2719)2811239$$aDrzezga, Alexander$$b13
000283059 7001_ $$00009-0005-3118-365X$$aBuckley, Christopher$$b14
000283059 7001_ $$00000-0002-6155-0642$$aGispert, Juan Domingo$$b15
000283059 7001_ $$00000-0002-0726-723X$$aFarrar, Gill$$b16
000283059 7001_ $$00000-0003-3543-3706$$aBarkhof, Frederik$$b17
000283059 773__ $$0PERI:(DE-600)2832891-7$$a10.1002/trc2.70190$$gVol. 11, no. 4, p. e70190$$n4$$pe70190$$tAlzheimer's & dementia / Translational research & clinical interventions$$v11$$x2352-8737$$y2025
000283059 8564_ $$uhttps://pub.dzne.de/record/283059/files/DZNE-2025-1466.pdf$$yRestricted
000283059 8564_ $$uhttps://pub.dzne.de/record/283059/files/DZNE-2025-1466.pdf?subformat=pdfa$$xpdfa$$yRestricted
000283059 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2811239$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b13$$kDZNE
000283059 9131_ $$0G:(DE-HGF)POF4-353$$1G:(DE-HGF)POF4-350$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lNeurodegenerative Diseases$$vClinical and Health Care Research$$x0
000283059 915__ $$0StatID:(DE-HGF)3001$$2StatID$$aDEAL Wiley$$d2025-01-07$$wger
000283059 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bALZH DEMENT-TRCI : 2022$$d2025-01-07
000283059 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2025-01-07
000283059 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2025-01-07
000283059 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2024-08-08T17:09:24Z
000283059 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2024-08-08T17:09:24Z
000283059 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Anonymous peer review$$d2024-08-08T17:09:24Z
000283059 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2025-01-07
000283059 915__ $$0StatID:(DE-HGF)0112$$2StatID$$aWoS$$bEmerging Sources Citation Index$$d2025-01-07
000283059 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2025-01-07
000283059 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2025-01-07
000283059 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2025-01-07
000283059 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2025-01-07
000283059 9201_ $$0I:(DE-2719)1011202$$kAG Boecker$$lPositron Emissions Tomography (PET)$$x0
000283059 980__ $$ajournal
000283059 980__ $$aEDITORS
000283059 980__ $$aVDBINPRINT
000283059 980__ $$aI:(DE-2719)1011202
000283059 980__ $$aUNRESTRICTED